Policy guidelines for risk-sharing agreements in South Africa
Background: Biological medicines are clinically effective but very expensive in South Africa. The business decisions of biological manufacturers and payers (medical schemes) impact the access patient's have to biological medicines. The paper is the second paper of a two part series that explore...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2008-10-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/1054 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|